Vascular thiol isomerases

Blood

Volumn 128, Issue 7, 2016, Pages 893-901

  Flaumenhaft, Robert ^a   Furie, Bruce ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ISOMERASE; MULTIFUNCTIONAL ENZYME; THIOL DERIVATIVE; THIOL ISOMERASE; THROMBOSPONDIN; UNCLASSIFIED DRUG; PROTEIN DISULFIDE ISOMERASE;

ALLOSTERISM; BLOOD CLOTTING; BLOOD CLOTTING DISORDER; BLOOD VESSEL; DISULFIDE BOND; DRUG TARGETING; ENDOTHELIUM CELL; ENZYME INHIBITION; HEMOSTASIS; HUMAN; HYPOTHESIS; NITROSYLATION; NONHUMAN; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; REVIEW; THROMBOSIS; ANIMAL; BIOLOGICAL MODEL; ENZYMOLOGY; METABOLISM; PATHOLOGY;

ANIMALS; BLOOD VESSELS; HEMOSTASIS; HUMANS; MODELS, BIOLOGICAL; OXIDATION-REDUCTION; PROTEIN DISULFIDE-ISOMERASES; THROMBOSIS;

EID: 85007454758     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2016-04-636456     Document Type: Review

References (94)

1. Sela M, White FH Jr, Anfinsen CB. Reductive cleavage of disulfide bridges in ribonuclease. Science. 1957;125(3250):691-692.
2. Dani HM, Fielder JA, Rabin BR. Degranulation and sex-specific regranulation of reticular membranes from rat liver as studied using a spectrophotometric assay of protein disulphide isomerase. FEBS Lett. 1976;65(3):377-382.
3. Goldberger RF, Epstein CJ, Anfinsen CB. Acceleration of reactivation of reduced bovine pancreatic ribonuclease by a microsomal system from rat liver. J Biol Chem. 1963;238:628-635.
4. Bulleid NJ, Freedman RB. Defective cotranslational formation of disulphide bonds in protein disulphide-isomerase-deficient microsomes. Nature. 1988;335(6191):649-651.
5. Ellgaard L, Ruddock LW. The human protein disulphide isomerase family: substrate interactions and functional properties. EMBO Rep. 2005;6(1):28-32.
6. Qin J, Clore GM, Gronenborn AM. The highresolution three-dimensional solution structures of the oxidized and reduced states of human thioredoxin. Structure. 1994;2(6):503-522.
7. Weichsel A, Gasdaska JR, Powis G, Montfort WR. Crystal structures of reduced, oxidized, and mutated human thioredoxins: evidence for a regulatory homodimer. Structure. 1996;4(6):735-751.
8. McArthur AG, Knodler LA, Silberman JD, Davids BJ, Gillin FD, Sogin ML. The evolutionary origins of eukaryotic protein disulfide isomerase domains: new evidence from the Amitochondriate protist Giardia lamblia. Mol Biol Evol. 2001;18(8):1455-1463.
9. Zhou J, Wu Y, Wang L, et al. The C-terminal CGHC motif of protein disulfide isomerase supports thrombosis. J Clin Invest. 2015;125(12):4391-4406.
10. Tian G, Xiang S, Noiva R, Lennarz WJ, Schindelin H. The crystal structure of yeast protein disulfide isomerase suggests cooperativity between its active sites. Cell. 2006;124(1):61-73.
11. Song JL, Wang CC. Chaperone-like activity of protein disulfide-isomerase in the refolding of rhodanese. Eur J Biochem. 1995;231(2):312-316.
12. Yao Y, Zhou Y, Wang C. Both the isomerase and chaperone activities of protein disulfide isomerase are required for the reactivation of reduced and denatured acidic phospholipase A2. EMBO J. 1997;16(3):651-658.
13. Zai A, Rudd MA, Scribner AW, Loscalzo J. Cellsurface protein disulfide isomerase catalyzes transnitrosation and regulates intracellular transfer of nitric oxide. J Clin Invest. 1999;103(3):393-399.
14. Sliskovic I, Raturi A, Mutus B. Characterization of the S-denitrosation activity of protein disulfide isomerase. J Biol Chem. 2005;280(10):8733-8741.
15. Ramachandran N, Root P, Jiang XM, Hogg PJ, Mutus B. Mechanism of transfer of NO from extracellular S-nitrosothiols into the cytosol by cell-surface protein disulfide isomerase. Proc Natl Acad Sci USA. 2001;98(17):9539-9544.
16. Uys JD, Xiong Y, Townsend DM. Nitrosative stressinduced S-glutathionylation of protein disulfide isomerase. Methods Enzymol. 2011;490:321-332.
17. Townsend DM, Manevich Y, He L, et al. Nitrosative stress-induced s-glutathionylation of protein disulfide isomerase leads to activation of the unfolded protein response. Cancer Res. 2009; 69(19):7626-7634.
18. Murphy DD, Reddy EC, Moran N, O'Neill S. Regulation of platelet activity in a changing redox environment. Antioxid Redox Signal. 2014;20(13): 2074-2089.
19. Go Y-M, Jones DP. Intracellular proatherogenic events and cell adhesion modulated by extracellular thiol/disulfide redox state. Circulation. 2005;111(22):2973-2980.
20. Lundström J, Holmgren A. Determination of the reduction-oxidation potential of the thioredoxinlike domains of protein disulfide-isomerase from the equilibrium with glutathione and thioredoxin. Biochemistry. 1993;32(26):6649-6655.
21. Swiatkowska M, Padula G, Michalec L, Stasiak M, Skurzynski S, Cierniewski CS. Ero1alpha is expressed on blood platelets in association with protein-disulfide isomerase and contributes to redox-controlled remodeling of alphaIIbbeta3. J Biol Chem. 2010;285(39):29874-29883.
22. Laurindo FRM, Pescatore LA, Fernandes DC. Protein disulfide isomerase in redox cell signaling and homeostasis. Free Radic Biol Med. 2012; 52(9):1954-1969.
23. Wang C, Li W, Ren J, et al. Structural insights into the redox-regulated dynamic conformations of human protein disulfide isomerase. Antioxid Redox Signal. 2013;19(1):36-45.
24. Wang C, Yu J, Huo L, Wang L, Feng W, Wang CC. Human protein-disulfide isomerase is a redoxregulated chaperone activated by oxidation of domain a′. J Biol Chem. 2012;287(2):1139-1149.
25. Bekendam RH, Bendapudi P, Lin L, et al. A substrate-driven allosteric switch that enhances PDI catalytic activity. Nat Commun. In press.
26. Burgess JK, Hotchkiss KA, Suter C, et al. Physical proximity and functional association of glycoprotein 1balpha and protein-disulfide isomerase on the platelet plasma membrane. J Biol Chem. 2000;275(13):9758-9766.
27. Summers FA, Forsman Quigley A, Hawkins CL. Identification of proteins susceptible to thiol oxidation in endothelial cells exposed to hypochlorous acid and N-chloramines. Biochem Biophys Res Commun. 2012;425(2):157-161.
28. Fernando MR, Nanri H, Yoshitake S, Nagata-Kuno K, Minakami S. Thioredoxin regenerates proteins inactivated by oxidative stress in endothelial cells. Eur J Biochem. 1992;209(3):917-922.
29. Ejima K, Nanri H, Araki M, Uchida K, Kashimura M, Ikeda M. 17beta-estradiol induces protein thiol/disulfide oxidoreductases and protects cultured bovine aortic endothelial cells from oxidative stress. Eur J Endocrinol. 1999;140(6):608-613.
30. Ioannou Y, Zhang J-Y, Passam FH, et al. Naturally occurring free thiols within beta 2-glycoprotein I in vivo: nitrosylation, redox modification by endothelial cells, and regulation of oxidative stress-induced cell injury. Blood. 2010;116(11):1961-1970.
31. Shah CM, Bell SE, Locke IC, Chowdrey HS, Gordge MP. Interactions between cell surface protein disulphide isomerase and S-nitrosoglutathione during nitric oxide delivery. Nitric Oxide. 2007;16(1):135-142.
32. Irwin C, Roberts W, Naseem KM. Nitric oxide inhibits platelet adhesion to collagen through cGMP-dependent and independent mechanisms: the potential role for S-nitrosylation. Platelets. 2009;20(7):478-486.
33. Uehara T, Nakamura T, Yao D, et al. Snitrosylated protein-disulphide isomerase links protein misfolding to neurodegeneration. Nature. 2006;441(7092):513-517.
34. Walsh GM, Leane D, Moran N, et al. S-Nitrosylation of platelet alphaIIbbeta3 as revealed by Raman spectroscopy. Biochemistry. 2007;46(21):6429-6436.
35. Bell SE, Shah CM, Gordge MP. Protein disulfideisomerase mediates delivery of nitric oxide redox derivatives into platelets. Biochem J. 2007;403(2): 283-288.
36. Holbrook LM, Watkins NA, Simmonds AD, Jones CI, Ouwehand WH, Gibbins JM. Platelets release novel thiol isomerase enzymes which are recruited to the cell surface following activation. Br J Haematol. 2010;148(4):627-637.
37. Galligan JJ, Petersen DR. The human protein disulfide isomerase gene family. Hum Genomics. 2012;6:6.
38. Chen K, Lin Y, Detwiler TC. Protein disulfide isomerase activity is released by activated platelets. Blood. 1992;79(9):2226-2228.
39. Essex DW, Chen K, Swiatkowska M. Localization of protein disulfide isomerase to the external surface of the platelet plasma membrane. Blood. 1995;86(6):2168-2173.
40. Chen K, Detwiler TC, Essex DW. Characterization of protein disulphide isomerase released from activated platelets. Br J Haematol. 1995;90(2):425-431.
41. Essex DW, Li M. Protein disulphide isomerase mediates platelet aggregation and secretion. Br J Haematol. 1999;104(3):448-454.
42. Crescente M, Pluthero FG, Li L, et al. Intracellular Trafficking, Localization, and Mobilization of Platelet-Borne Thiol Isomerases. Arterioscler Thromb Vasc Biol. 2016;36(6):1164-1173.
43. Thon JN, Peters CG, Machlus KR, et al. T granules in human platelets function in TLR9 organization and signaling. J Cell Biol. 2012; 198(4):561-574.
44. Sharda A, Kim SH, Jasuja R, et al. Defective PDI release from platelets and endothelial cells impairs thrombus formation in Hermansky-Pudlak syndrome. Blood. 2015;125(10):1633-1642.
45. Passam FH, Lin L, Gopal S, et al. Both platelet- and endothelial cell-derived ERp5 support thrombus formation in a laser-induced mouse model of thrombosis. Blood. 2015;125(14):2276-2285.
46. Kim K, Hahm E, Li J, et al. Platelet protein disulfide isomerase is required for thrombus formation but not for hemostasis in mice. Blood. 2013;122(6):1052-1061.
47. Mor-Cohen R. Disulfide Bonds as Regulators of Integrin Function in Thrombosis and Hemostasis. Antioxid Redox Signal. 2016;24(1):16-31.
48. Cho J, Kennedy DR, Lin L, et al. Protein disulfide isomerase capture during thrombus formation in vivo depends on the presence of β3 integrins. Blood. 2012;120(3):647-655.
49. Essex DW, Li M, Miller A, Feinman RD. Protein disulfide isomerase and sulfhydryl-dependent pathways in platelet activation. Biochemistry. 2001;40(20):6070-6075.
50. Lahav J, Wijnen EM, Hess O, et al. Enzymatically catalyzed disulfide exchange is required for platelet adhesion to collagen via integrin alpha2beta1. Blood. 2003;102(6):2085-2092.
51. Hotchkiss KA, Chesterman CN, Hogg PJ. Catalysis of disulfide isomerization in thrombospondin 1 by protein disulfide isomerase. Biochemistry. 1996;35(30):9761-9767.
52. Huang EM, Detwiler TC, Milev Y, Essex DW. Thiol-disulfide isomerization in thrombospondin: effects of conformation and protein disulfide isomerase. Blood. 1997;89(9):3205-3212.
53. Hotchkiss KA, Matthias LJ, Hogg PJ. Exposure of the cryptic Arg-Gly-Asp sequence in thrombospondin-1 by protein disulfide isomerase. Biochim Biophys Acta. 1998;1388(2):478-488.
54. Essex DW, Miller A, Swiatkowska M, Feinman RD. Protein disulfide isomerase catalyzes the formation of disulfide-linked complexes of vitronectin with thrombin-antithrombin. Biochemistry. 1999;38(32):10398-10405.
55. Jordan PA, Stevens JM, Hubbard GP, et al. A role for the thiol isomerase protein ERP5 in platelet function. Blood. 2005;105(4):1500-1507.
56. Holbrook LM, Sasikumar P, Stanley RG, Simmonds AD, Bicknell AB, Gibbins JM. The platelet-surface thiol isomerase enzyme ERp57 modulates platelet function. J Thromb Haemost. 2012;10(2):278-288.
57. Wu Y, Ahmad SS, Zhou J, Wang L, Cully MP, Essex DW. The disulfide isomerase ERp57 mediates platelet aggregation, hemostasis, and thrombosis. Blood. 2012;119(7):1737-1746.
58. Donoghue N, Yam PT, Jiang XM, Hogg PJ. Presence of closely spaced protein thiols on the surface of mammalian cells. Protein Sci. 2000; 9(12):2436-2445.
59. Swiatkowska M, Szymański J, Padula G, Cierniewski CS. Interaction and functional association of protein disulfide isomerase with alphaVbeta3 integrin on endothelial cells. FEBS J. 2008;275(8):1813-1823.
60. Wan S-W, Lin C-F, Lu Y-T, Lei HY, Anderson R, Lin YS. Endothelial cell surface expression of protein disulfide isomerase activates β1 and β3 integrins and facilitates dengue virus infection. J Cell Biochem. 2012;113(5):1681-1691.
61. Popescu NI, Lupu C, Lupu F. Extracellular protein disulfide isomerase regulates coagulation on endothelial cells through modulation of phosphatidylserine exposure. Blood. 2010;116(6): 993-1001.
62. Zhang LM, St Croix C, Cao R, et al. Cell-surface protein disulfide isomerase is required for transnitrosation of metallothionein by S-nitrosoalbumin in intact rat pulmonary vascular endothelial cells. Exp Biol Med (Maywood). 2006;231(9): 1507-1515.
63. Jasuja R, Furie B, Furie BC. Endothelium-derived but not platelet-derived protein disulfide isomerase is required for thrombus formation in vivo. Blood. 2010;116(22):4665-4674.
64. Falati S, Gross P, Merrill-Skoloff G, Furie BC, Furie B. Real-time in vivo imaging of platelets, tissue factor and fibrin during arterial thrombus formation in the mouse. Nat Med. 2002;8(10):1175-1181.
65. Chen VM, Ahamed J, Versteeg HH, Berndt MC, Ruf W, Hogg PJ. Evidence for activation of tissue factor by an allosteric disulfide bond. Biochemistry. 2006;45(39):12020-12028.
66. Ahamed J, Versteeg HH, Kerver M, et al. Disulfide isomerization switches tissue factor from coagulation to cell signaling. Proc Natl Acad Sci USA. 2006;103(38):13932-13937.
67. Cho J, Furie BC, Coughlin SR, Furie B. A critical role for extracellular protein disulfide isomerase during thrombus formation in mice. J Clin Invest. 2008;118(3):1123-1131.
68. Reinhardt C, von Brühl ML, Manukyan D, et al. Protein disulfide isomerase acts as an injury response signal that enhances fibrin generation via tissue factor activation. J Clin Invest. 2008;118(3):1110-1122.
69. Jasuja R, Passam FH, Kennedy DR, et al. Protein disulfide isomerase inhibitors constitute a new class of antithrombotic agents. J Clin Invest. 2012;122(6):2104-2113.
70. Schulman S, Bendapudi P, Sharda A, et al. Extracellular Thiol Isomerases and Their Role in Thrombus Formation. Antioxid Redox Signal. 2016;24(1):1-15.
71. Wang L, Wu Y, Zhou J, et al. Platelet-derived ERp57 mediates platelet incorporation into a growing thrombus by regulation of the αIIbβ3 integrin. Blood. 2013;122(22):3642-3650.
72. Zhu S, Welsh JD, Brass LF, Diamond SL. Platelet-targeting thiol reduction sensor detects thiol isomerase activity on activated platelets in mouse and human blood under flow. J Thromb Haemost. 2016;14(5):1070-1081.
73. Chen VM, Hogg PJ. Allosteric disulfide bonds in thrombosis and thrombolysis. J Thromb Haemost. 2006;4(12):2533-2541.
74. Butera D, Cook KM, Chiu J, Wong JWH, Hogg PJ. Control of blood proteins by functional disulfide bonds. Blood. 2014;123(13):2000-2007.
75. Leader A, Mor-Cohen R, Ram R, et al. The role of protein disulfide isomerase in the post-ligation phase of β3 integrin-dependent cell adhesion. Thromb Res. 2015;136(6):1259-1265.
76. Hahm E, Li J, Kim K, et al. Extracellular protein disulfide isomerase regulates ligand-binding activity of αMβ2 integrin and neutrophil recruitment during vascular inflammation. Blood. 2013;121(19):3789-3800.
77. Langer F, Ruf W. Synergies of phosphatidylserine and protein disulfide isomerase in tissue factor activation. Thromb Haemost. 2014;111(4):590-597.
78. Popescu NI, Lupu C, Lupu F. Role of PDI in regulating tissue factor: FVIIa activity. Thromb Res. 2010;125(Suppl 1):S38-S41.
79. Primm TP, Gilbert HF. Hormone binding by protein disulfide isomerase, a high capacity hormone reservoir of the endoplasmic reticulum. J Biol Chem. 2001;276(1):281-286.
80. Lin L, Gopal S, Sharda A, et al. Quercetin-3-rutinoside Inhibits Protein Disulfide Isomerase by Binding to Its b'x Domain. J Biol Chem. 2015; 290(39):23543-23552.
81. Cui G, Shan L, Guo L, et al. Novel anti-thrombotic agent for modulation of protein disulfide isomerase family member ERp57 for prophylactic therapy. Sci Rep. 2015;5:10353.
82. McCullough ML, Peterson JJ, Patel R, Jacques PF, Shah R, Dwyer JT. Flavonoid intake and cardiovascular diseasemortality in a prospective cohort of US adults. Am J Clin Nutr. 2012;95(2):454-464.
83. Geleijnse JM, Launer LJ, Van der Kuip DA, Hofman A, Witteman JC. Inverse association of tea and flavonoid intakes with incident myocardial infarction: the Rotterdam Study. Am J Clin Nutr. 2002;75(5):880-886.
84. Flaumenhaft R, Furie B, Zwicker JI. Therapeutic implications of protein disulfide isomerase inhibition in thrombotic disease. Arterioscler Thromb Vasc Biol. 2015;35(1):16-23.
85. Manickam N, Sun X, Hakala KW, Weintraub ST, Essex DW. Thiols in the alphaIIbbeta3 integrin are necessary for platelet aggregation. Br J Haematol. 2008;142(3):457-465.
86. Jurk K, Lahav J, VAN Aken H, Brodde MF, Nofer JR, Kehrel BE. Extracellular protein disulfide isomerase regulates feedback activation of platelet thrombin generation via modulation of coagulation factor binding. J Thromb Haemost. 2011;9(11):2278-2290.
87. Huizing M, Boissy RE, Gahl WA. Hermansky-Pudlak syndrome: vesicle formation from yeast to man. Pigment Cell Res. 2002;15(6):405-419.
88. Nagayama S, Yokoi T, Tanaka H, Kawaguchi Y, Shirasaka T, Kamataki T. Occurrence of autoantibody to protein disulfide isomerase in patients with hepatic disorder. J Toxicol Sci. 1994;19(3):163-169.
89. Aran A, Weiner K, Lin L, et al. Post-streptococcal auto-antibodies inhibit protein disulfide isomerase and are associated with insulin resistance. PLoS One. 2010;5(9):e12875.
90. Caorsi C, Niccolai E, Capello M, et al. Protein disulfide isomerase A3-specific Th1 effector cells infiltrate colon cancer tissue of patients with circulating anti-protein disulfide isomerase A3 autoantibodies. Transl Res. 2016;171:17-28.e2.
91. Shen J, Wang W, Wu J, et al. Comparative proteomic profiling of human bile reveals SSP411 as a novel biomarker of cholangiocarcinoma. PLoS One. 2012;7(10):e47476.
92. Komurasaki R, Imaoka S, Tada N, Okada K, Nishiguchi S, Funae Y. LKM-1 sera from autoimmune hepatitis patients that recognize ERp57, carboxylesterase 1 and CYP2D6. Drug Metab Pharmacokinet. 2010;25(1):84-92.
93. Versteeg HH, Ruf W. Tissue factor coagulant function is enhanced by protein-disulfide isomerase independent of oxidoreductase activity. J Biol Chem. 2007;282(35):25416-25424.
94. Brophy TM, Coller BS, Ahamed J. Identification of the thiol isomerase-binding peptide, mastoparan, as a novel inhibitor of shear-induced transforming growth factor β1 (TGF-β1) activation. J Biol Chem. 2013;288(15):10628-10639.